A detailed history of Hrt Financial LP transactions in Novavax Inc stock. As of the latest transaction made, Hrt Financial LP holds 1,245,708 shares of NVAX stock, worth $8.68 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,245,708
Previous 615,649 102.34%
Holding current value
$8.68 Million
Previous $3.88 Million 178.49%
% of portfolio
0.05%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.56 - $9.71 $4.13 Million - $6.12 Million
630,059 Added 102.34%
1,245,708 $10.8 Million
Q2 2025

Aug 14, 2025

BUY
$5.43 - $7.74 $2.2 Million - $3.13 Million
404,676 Added 191.81%
615,649 $3.88 Million
Q1 2025

May 15, 2025

BUY
$6.41 - $10.82 $1.35 Million - $2.28 Million
210,973 New
210,973 $1.35 Million
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $376,810 - $538,933
55,332 New
55,332 $400,000
Q4 2022

Feb 10, 2023

BUY
$8.86 - $25.04 $1.08 Million - $3.04 Million
121,545 Added 201.32%
181,919 $1.87 Million
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $1.1 Million - $4.6 Million
60,374 New
60,374 $1.1 Million
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $19.4 Million - $29.6 Million
-109,286 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$121.0 - $257.67 $4.85 Million - $10.3 Million
40,042 Added 57.83%
109,286 $23.2 Million
Q1 2021

May 17, 2021

BUY
$112.98 - $319.93 $7.82 Million - $22.2 Million
69,244 New
69,244 $12.6 Million
Q4 2020

Feb 16, 2021

SELL
$78.74 - $139.5 $401,022 - $710,473
-5,093 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$79.44 - $178.51 $404,587 - $909,151
5,093 New
5,093 $551,000
Q1 2020

May 15, 2020

SELL
$3.93 - $16.0 $106,051 - $431,760
-26,985 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.69 - $5.22 $50,021 - $70,762
13,556 Added 100.95%
26,985 $107,000
Q3 2019

Nov 14, 2019

BUY
$4.02 - $7.84 $53,984 - $105,283
13,429 New
13,429 $67,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $545M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.